Optimal management of renal cell carcinoma in the elderly: a review

References

• MartinJESheaffMTThe pathology of ageing: concepts and mechanismsJ Pathol2007211211111317200949
   PubMed Web of Science ®Google Scholar
• CohenHTMcGovernFJRenal-cell carcinomaN Engl J Med2005353232477249016339096
   PubMed Web of Science ®Google Scholar
• KovacsGAkhtarMBeckwithBJThe Heidelberg classification of renal cell tumoursJ Pathol199718321311339390023
   PubMed Web of Science ®Google Scholar
• MotzerRJBanderNHNanusDMRenal-cell carcinomaN Engl J Med1996335128658758778606
   PubMed Web of Science ®Google Scholar
• MotzerRJHutsonTETomczakPSunitinib versus interferon alfa in metastatic renal-cell carcinomaN Engl J Med2007356211512417215529
   PubMed Web of Science ®Google Scholar
• EscudierBEisenTStadlerWMSorafenib in advanced clear-cell renal-cell carcinomaN Engl J Med2007356212513417215530
   PubMed Web of Science ®Google Scholar
• MotzerRJEscudierBOudardSEfficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trialLancet2008372963744945618653228
   PubMed Web of Science ®Google Scholar
• HudesGCarducciMTomczakPTemsirolimus, interferon alfa, or both for advanced renal-cell carcinomaN Engl J Med2007356222271228117538086
   PubMed Web of Science ®Google Scholar
• EscudierBPluzanskaAKoralewskiPBevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trialLancet200737096052103211118156031
   PubMed Web of Science ®Google Scholar
• SternbergCNDavisIDMardiakJPazopanib in locally advanced or metastic renal cell carcinoma: results of a randomised phase III trialJ Clin Oncol20102881061106820100962
   PubMed Web of Science ®Google Scholar
• RiniBIEscudierBTomczakPComparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trialLancet201137898071931193922056247
   PubMed Web of Science ®Google Scholar
• FerlayJParkinDMSteliarova-FoucherEEstimates of cancer incidence and mortality in Europe in 2008Eur J Cancer201046476578120116997
   PubMed Web of Science ®Google Scholar
• SiegelRNaishadhamDJemalACancer statisticsCA Cancer J Clin2012621102922237781
   PubMed Web of Science ®Google Scholar
• Seer.cancer.gov. Cancer of the kidney and renal pelvis — SEER stat fact sheets Available from: http://seer.cancer.gov/statfacts/html/kidrp.htmlAccessed March 6, 2013
   Google Scholar
• LamJSLeppertJTBelldegrunASFiglinRANovel approaches in the therapy of metastatic renal cell carcinomaWorld J Urol200523320221215812574
   PubMed Web of Science ®Google Scholar
• MotzerRJBanderNHNanusDMRenal-cell carcinomaN Engl J Med1996335128658758778606
   PubMed Web of Science ®Google Scholar
• JanzenNKKimHLFiglinRABelldegrunASSurveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent diseaseUrol Clin North Am200330484385214680319
   PubMed Web of Science ®Google Scholar
• YancikRGanzPAVarricchioCGConleyBPerspectives on comorbidity and cancer in older patients: approaches to expand the knowledge baseJ Clin Oncol20011941147115111181680
   PubMed Web of Science ®Google Scholar
• KirkaliZKidney cancer in the elderlyUrol Oncol200927667367619879478
   PubMed Web of Science ®Google Scholar
• CharlsonMEPompeiPAlesKLMacKenzieCRA new method of classifying prognostic comorbidity in longitudinal studies: development and validationJ Chronic Dis19874053733833558716
   PubMedGoogle Scholar
• HallJCHallJLASA status and age predict adverse events after abdominal surgeryJ Qual Clin Pract1996161031088794400
   PubMedGoogle Scholar
• Wieland D, Hirth V Comprehensive geriatric assessmentCancer Control20031045446214652521
   PubMedGoogle Scholar
• BalducciLExtermannMManagement of the frail person with advanced cancerCritical Rev Oncol Hematol200033214314810737376
   PubMed Web of Science ®Google Scholar
• LeeSJLindquistKSegalMRCovinskyKEDevelopment and validation of a prognostic index for 4-year mortality in older adultsJAMA2006295780180816478903
   PubMed Web of Science ®Google Scholar
• CareyECWalterLCLindquistKCovinskyKEDevelopment and validation of a functional morbidity index to predict mortality in community-dwelling eldersJ Gen Intern Med200419101027103315482555
   PubMed Web of Science ®Google Scholar
• SunMThuretRAbdollahFAge-adjusted incidence, mortality, and survival rates of stage-specific renal cell carcinoma in North America: a trend analysisEur Urol201159113514121035250
   PubMed Web of Science ®Google Scholar
• FrankIBluteMLChevilleJCLohseCMWeaverALZinckeHSolid renal tumors: an analysis of pathological features related to tumor sizeJ Urol20031706 Pt 12217222014634382
   PubMed Web of Science ®Google Scholar
• VolpeAMattarKFinelliAKachuraJREvansAJGeddieWRContemporary results of percutaneous biopsy of 100 small renal masses: a single center experienceJ Urol200818062333233718930274
   PubMed Web of Science ®Google Scholar
• VolpeAKachuraJRGeddieWREvansAJGharajehASaravananATechniques, safety and accuracy of sampling of renal tumors by fine needle aspiration and core biopsyJ Urol2007178237938617561170
   PubMed Web of Science ®Google Scholar
• EscudierBEisenTPortaCRenal cell carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-upAnn Oncol201223Suppl 7657121436185
   PubMed Web of Science ®Google Scholar
• VolpeACadedduJACestariAContemporary management of small renal massesEur Urol201160350151521664040
   PubMed Web of Science ®Google Scholar
• Al-QudahHSRodriguezARSextonWJLaparoscopic management of kidney cancer: updated reviewCancer Control200714321823017615527
   PubMedGoogle Scholar
• PortisAJYanYLandmanJLong-term followup after laparoscopic radical nephrectomyJ Urol200216731257126211832709
   PubMed Web of Science ®Google Scholar
• GuzzoTJAllafMEPierorazioPMPerioperative outcomes of elderly patients undergoing laparoscopic renal proceduresUrology200973357257619118876
   PubMed Web of Science ®Google Scholar
• FrankIBluteMLLeibovichBCChevilleJCLohseCMZinckeHIndependent validation of the 2002 American Joint Committee on Cancer primary tumor classification for renal cell carcinoma using a large, single institution cohortJ Urol200517361889189215879769
   PubMed Web of Science ®Google Scholar
• GoASChertowGMFanDMcCullochCEHsuCChronic kidney disease and the risks of death, cardiovascular events, and hospitalizationN Engl J Med2004351131296130515385656
   PubMed Web of Science ®Google Scholar
• Van PoppelHDa PozzoLAlbrechtWA prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinomaEur Urol201159454355221186077
   PubMed Web of Science ®Google Scholar
• PatardJ-JShvartsOLamJSSafety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experienceJ Urol20041716 Pt 121812185 quiz 243515126781
   PubMed Web of Science ®Google Scholar
• SimmonsMNWeightCJGillISLaparoscopic radical versus partial nephrectomy for tumors > 4 cm: intermediate-term oncologic and functional outcomesUrology20097351077108219394509
   PubMed Web of Science ®Google Scholar
• Van PoppelHDa PozzoLAlbrechtWA prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinomaEur Urol20075161606161517140723
   PubMed Web of Science ®Google Scholar
• LauWKBluteMLWeaverALTorresVEZinckeHMatched comparison of radical nephrectomy vs nephron sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidneyMayo Clin Proc2000751236124211126830
   PubMed Web of Science ®Google Scholar
• La RochelleJShuchBRiggsSFunctional and oncological outcomes of partial nephrectomy of solitary kidneysJ Urol200918152037204219298974
   PubMed Web of Science ®Google Scholar
• LesageKJoniauSFransisKVan PoppelHComparison between open partial and radical nephrectomy for renal tumours: perioperative outcome and health-related quality of lifeEur Urol200751361462017097216
   PubMed Web of Science ®Google Scholar
• HellenthalNJMansourAMHaynMHSchwaabTRenal cell carcinoma in octogenarians: nephron sparing surgery should remain the standard of careJ Urol2011185241542021167523
   PubMed Web of Science ®Google Scholar
• BerdjisNHakenbergOWNovotnyVFroehnerMWirthMPTreating renal cell cancer in the elderlyBJU Int200697470370516536757
   PubMed Web of Science ®Google Scholar
• StaehlerMHasekeNStadlerTRenal surgery in the elderly: morbidity in patients aged > 75 years in a contemporary seriesBJU Int2008102668468718510657
   PubMed Web of Science ®Google Scholar
• RoosFCPahernikSMelchiorSWThüroffJWRenal tumour surgery in elderly patientsBJU Int2008102668068318410435
   PubMed Web of Science ®Google Scholar
• KunkleDAUzzoRGCryoablation or radiofrequency ablation of the small renal mass: a meta-analysisCancer2008113102671268018816624
   PubMed Web of Science ®Google Scholar
• CarrafielloGLaganàDIannielloAPercutaneous radiofrequency thermal ablation of renal cell carcinoma: is it possible a day-hospital treatment?Int J Surg20086Suppl 1s31s3519200792
   PubMedGoogle Scholar
• TracyCRRamanJDDonnallyCTrimmerCKCadedduJADurable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 yearsCancer2010116133135314220564644
   PubMed Web of Science ®Google Scholar
• ChoueiriTKSchutzFABHeveloneNDThermal ablation vs surgery for localized kidney cancer: a Surveillance, Epidemiology, and End Results (SEER) database analysisUrology2011781939821550636
   PubMed Web of Science ®Google Scholar
• KlatteTGrubmüllerBWaldertMWeiblPRemziMLaparoscopic cryoablation versus partial nephrectomy for the treatment of small renal masses: systematic review and cumulative analysis of observational studiesEur Urol201160343544321616582
   PubMed Web of Science ®Google Scholar
• CornellsFBalageasPLe BrasYRadiologically-guided thermal ablation of renal tumoursDiagn Interv Imaging201293424626122464994
   PubMedGoogle Scholar
• SchmitGDThompsonRHKurupANPercutaneous cryoablation of solitary sporadic renal cell carcinomasBJU Int201318913035
   Google Scholar
• BosniakMABirnbaumBAKrinskyGAWaismanJSmall renal parenchymal neoplasms: further observations on growthRadiology199519735895977480724
   PubMed Web of Science ®Google Scholar
• Abou YoussifTKassoufWSteinbergJAprikianAGLaplanteMPTanguaySActive surveillance for selected patients with renal masses: updated results with long-term follow-upCancer200711051010101417628489
   PubMed Web of Science ®Google Scholar
• ChawlaSNCrispenPLHanlonALGreenbergREChenDYTUzzoRGThe natural history of observed enhancing renal masses: meta-analysis and review of the world literatureJ Urol2006175242543116406965
   PubMed Web of Science ®Google Scholar
• LagunaMPKümmerlinIRiojaJde la RosetteJJBiopsy of a renal mass: where are we now?Curr Opin Urol20091954475319571757
   PubMed Web of Science ®Google Scholar
• BeislandCHjelleKMReisaeterLARBostadLObservation should be considered as an alternative in management of renal masses in older and comorbid patientsEur Urol20095561419142719147267
   PubMed Web of Science ®Google Scholar
• LaneBRAbaouassalyRGaoTActive treatment of localized renal tumors may not impact overall survival in patients aged 75 years or olderCancer2010116133119312620564627
   PubMed Web of Science ®Google Scholar
• NegrierSEscudierBLassetCRecombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinomaN Engl J Med199833818127212789562581
   PubMed Web of Science ®Google Scholar
• CoebergJWJanssen-HeijnenMLPostPNRazenbergPPSerious co-morbidity among unselected cancer patients newly diagnosed in the southeastern part of The Netherlands in 1993–1996J Clin Epidemiol199952121131113610580775
   PubMed Web of Science ®Google Scholar
• BellmuntJNegrierSEscudierBAwadaAAaproMSIOG TaskforceThe medical treatment of metastatic renal cell cancer in the elderly: position paper of a SIOG taskforceCrit Rev Oncol Hematol2009691647218774306
   PubMed Web of Science ®Google Scholar
• HustonTEBukowskiRMRiniBIA pooled analysis of the efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinomaJ Clin Oncol201129Suppls4604
   PubMed Web of Science ®Google Scholar
• de GiogiURihawiKLo ReGSunitinib as first-line therapy in elderly patients (age 70 and older) with metastatic renal cell cancerJ Clin Oncol201230Suppl 5s411
   Web of Science ®Google Scholar
• MotzerRJMichaelsonMDRedmanBGActivity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinomaJ Clin Oncol2006241162416330672
   PubMed Web of Science ®Google Scholar
• EisenTOudardSSzczylikCSorafenib for older patients with renal cell carcinoma: subset analysis from a randomized trialJ Natl Cancer Inst2008100201454146318840822
   PubMed Web of Science ®Google Scholar
• MelicharBKoralewskiPRavaudAFirst line bevacizumab combined with reduced dose interferon alpha-2a is active in patients with metastatic renal cell carcinomaAnn Oncol2008191470147618408224
   PubMed Web of Science ®Google Scholar
• DutcherJPTannirNBellmuntJEscudierBExperience with sorafenib and the elderly patientMed Oncol20102741359137020043216
   PubMed Web of Science ®Google Scholar
• EscudierBPortaCBonoPPatient preference between pazopanib and sunitinib: results of a randomized double-blind, placebo-controlled, cross-over study in patients with metastatic renal cell carcinoma (mRCC)-PISCES study, NCT1064310J Clin Oncol201230SupplCRA4502
   Web of Science ®Google Scholar
• MotzerBHutsonTEReevesJRandomized, open-label, phase III trial of pazopanib versus sunitinib in first-line treatment of patients with metastatic renal cell carcinoma: results of the COMPARZ trialEuropean Society for Medical Oncology Conference2012 Sep 28––Oct 2Vienna, Austria
   Google Scholar